Skip to main content

Published locations for FDA OKs durvalumab combo for extensive-stage SCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA OKs durvalumab combo for extensive-stage SCLC

User login

  • Reset your password
  • /content/fda-oks-durvalumab-combo-extensive-stage-sclc
  • /fedprac/article/219832/lung-cancer/fda-oks-durvalumab-combo-extensive-stage-sclc
  • /oncologypractice/article/219832/lung-cancer/fda-oks-durvalumab-combo-extensive-stage-sclc
  • /fedprac/avaho/article/219832/lung-cancer/fda-oks-durvalumab-combo-extensive-stage-sclc
  • /jcomjournal/article/219832/lung-cancer/fda-oks-durvalumab-combo-extensive-stage-sclc
  • /hematology-oncology/article/219832/lung-cancer/fda-oks-durvalumab-combo-extensive-stage-sclc
  • /chestphysician/article/219832/lung-cancer/fda-oks-durvalumab-combo-extensive-stage-sclc